Clinical Trials
147 trialsCKD AGE
Centre Hospitalier Saint Joseph Saint Luc de Lyon
A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.
MindLight, LLC
Alternative-C
Ludwig-Maximilians - University of Munich
A Phase II Trial of Intermediate Radiation Dose For Lymphoma
Sunnybrook Health Sciences Centre
Trial-based Effectiveness and Cost-effectiveness of the Partner in Balance Intervention
Maastricht University
A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)
Fondazione Italiana Linfomi - ETS
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.
RONIN
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Biofeedback Training's Impact on Cognitive and Motor Skills in Kids With Intellectual Disabilities
University of Rzeszow
Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions
Massachusetts General Hospital
Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19
Huashan Hospital
First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies
NovalGen Ltd.
Choko-AGE
Universita di Verona
Computer-Mediated Intervention to Enhance Emotional Competence in Children With Autism in Schools
Bar-Ilan University, Israel
IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.
Chinese PLA General Hospital
m-sTBI
University of British Columbia
The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia
Deepsonbio
DRARCH
St. Joseph's Hospital and Medical Center, Phoenix
Evaluation of Effects of Bracket's Slot System on the Quantity and Quality of Teeth Movements During Orthodontic Leveling and Alignment Stage
Al-Azhar University
A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Zhejiang University
Herombopag + rhTPO in Severe Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University
PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
V-iCST
University College, London
Self-determination Enhancement Group for Adults With Mild Intellectual Disability and Their Caregivers in Hong Kong
Chinese University of Hong Kong
VOC-BPCO
Hopital Foch
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory CD19-positive Lymphoma.
Hrain Biotechnology Co., Ltd.
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
Cognito Therapeutics, Inc.
DVinCHI
University of Ulster
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
Gilead Sciences
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
Gilead Sciences
CBOT-OUD
Evon Medics LLC
COVID19REHAB
Centro Universitário de Anapolis
FLMRD
Meir Medical Center
PlaSenTer
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
FCM Versus R-FCM Followed by R-Maintenance or Observation Only
Ludwig-Maximilians - University of Munich
Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study
Ruijin Hospital
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies
Huazhong University of Science and Technology
Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma
Nanjing Sanhome Pharmaceutical, Co., Ltd.
A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma
Oncotartis, Inc.
A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Study of YY-20394 in Participants With Relapsed/Refractory Follicular Non-Hodgkin's Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd.
A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd.
Effectiveness, Tolerability and Safety of Three Formulations in Underfives With Moderate Acute Malnutrition
University of Uyo Teaching Hospital
A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients
Ruijin Hospital
HFNC vs Nasal Cannula in Mild Chronic Obstructive Pulmonary Disease Exacerbation
China-Japan Friendship Hospital
High Flow Nasal Cannula vs NPPV in Moderate Chronic Obstructive Pulmonary Disease Exacerbation
China-Japan Friendship Hospital
The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI
Tel-Aviv Sourasky Medical Center